Clinical Trial Update: Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial update on hydroxychloroquine as chemoprophylaxis for healthcare workers exposed to COVID-19 patients; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: National Institute of Respiratory Diseases, Mexico | Conditions: COVID-19, Severe Acute Respiratory Syndrome | Phase 3 | Status: COMPLETED